Prospects for the use of umbilical cord blood in the treatment of diseases of the cardiovascular system
Evaluation of the value and prospects of using cord blood stem cells in the treatment of cardiovascular diseases. Experimental and clinical studies of the effectiveness of treatment of ischemic and non-ischemic heart diseases using stem cells.
| Рубрика | Медицина |
| Вид | статья |
| Язык | английский |
| Дата добавления | 16.06.2024 |
| Размер файла | 769,5 K |
Отправить свою хорошую работу в базу знаний просто. Используйте форму, расположенную ниже
Студенты, аспиранты, молодые ученые, использующие базу знаний в своей учебе и работе, будут вам очень благодарны.
41. Karantalis V., DiFede D. L., Gerstenblith G., Pham S., Symes J., Zambrano J.P., Fishman J., Pattany P, McNiece I., Conte J., Schulman S., Wu K., Shah A., Breton E., Davis-Sproul J., Schwarz R., Feigenbaum G., Mushtaq M., Suncion V. Y., Lardo A. C., Borrello I., Mendizabal A., Karas T. Z., Byrnes J., Lowery M., Heldman A. W., Hare J. M. Autologous mesenchymal stem cells produce concordant improvements in regional function, tissue perfusion, and fibrotic burden when administered to patients undergoing coronary artery bypass grafting: The prospective randomized study of mesenchymal stem cell therapy in patients undergoing cardiac surgery (prometheus) trial. Circ Res. 2014, 114, 1302-1310. https://doi.org/10.1161/ CIRCRESAHA.114.303180
42. Razeghian-Jahromi I., MattaA. G., Canitrot R., Zibaeenezhad M. J., Razmkhah M., Safari A., Nader V., Roncalli J. Surfing the clinical trials of mesenchymal stem cell therapy in ischemic cardiomyopathy. Stem Cell Res Ther. 2021, 12(1), 361. https://doi. org/10.1186/s13287-021-02443-1
43. Najafi R., Sharifi A. M. Deferoxamine preconditioning potentiates mesenchymal stem cell homing in vitro and in streptozotocin-diabetic rats. Expert. Opin. Biol. Ther. 2013, 13(7), 959-972.
44. White I. A., Sanina C., Balkan W., Hare J. M. Mesenchymal Stem Cells in Cardiology. Methods Mol. Biol. 2016, 1416, 55-87. https://doi. org/10.1007/978-1-4939-3584-0_4
45. Deuse T., Stubbendorff M., Tang-Quan K., Phillips N., Kay M. A., Eiermann T., Phan T. T., Volk H. D., Reichenspurner H., Robbins R. C., Schrepfer S. Immunogenicity and immunomodulatory properties of umbilical cord lining mesenchymal stem cells. Cell Transplantation. 2011, 20(5), 655-667. https://doi.org/10.3727/096368910X536473
46. Song H. F., He S., Li S. H., Yin W. J., Wu J., Guo J., Shao Z. B., Zhai X. Y., Gong H., Lu L., Wei F., Weisel R. D., Xie J., Li R. K. Aged Human Multipotent Mesenchymal Stromal Cells Can Be Rejuvenated by Neuron-Derived Neurotrophic Factor and Improve Heart Function After Injury. JACC Basic Transl Sci. 2017, 2(6), 702-716. https://doi. org/10.1016/j.jacbts.2017.07.014
47. Donders R., Bogie J. F. J., Ravanidis S., Gervois P., Vanheusden M., Maree R., Schrynemackers M., Smeets H.J.M., Pinxte- ren J., Gijbels K., Walbers S., Mays R.W., Deans R., Van Den Bosch L., Stinissen P., Lambrichts I., Gyselaers W., Hellings N. Human Wharton's jelly-derived stem cells display a distinct immunomodulatory and proregenerative transcriptional signature compared to bone marrow-derived stem cells. Stem Cells Dev. 2018, 27, 65-84. https:// doi.org/10.1089/scd.2017.0029
48. Yang W. Z., Zhang Y., Wu F., Min W. P., Minev B., Zhang M., Luo X. L., Ramos F., Ichim T. E., Riordan N. H., Hu X. Safety evaluation of allogeneic umbilical cord blood mononuclear cell therapy for degenerative conditions. Journal of Translational Medicine. 2010, 8, 75. doi: 10.1186/14795876-8-75.
49. Dehn J., Spellman S., Hurley C. K., Shaw B. E., Barker J. N., Burns L. J., Confer D. L., Eapen M., Fernandez-Vina M., Hartzman R., Maiers M., Marino S. R., Mueller C., Perales M. A., Rajalingam R., Pidala J. Selection of unrelated donors and cord blood units for hematopoietic cell transplantation: guidelines from the NMDP/CIBMTR. Blood. 2019, 134(12), 924-934. https://doi. org/10.1182/blood.2019001212
50. Shi P. A., Luchsinger L. L., Greally J. M., Delaney C. S. Umbilical cord blood: an undervalued and underutilized resource in allogeneic hematopoietic stem cell transplant and novel cell therapy applications. Curr. Opin. Hematol. 2022, 29(6), 317-326. https://doi.org/10.1097/ MOH.0000000000000732
51. Spellman S. R. Hematology 2022-what is complete HLA match in 2022? Hematology Am Soc Hematol Educ Program. 2022, 2022(1), 83-89. https://doi.org/10.1182/ hematology.2022000326
52. Ashbridge B., Zehir A., Lubin M., Barker J. N., Moore M. A. Evaluation of Initial Telomere Length and Changes after Transplantation in Adult Double-Unit Cord Blood Transplant Recipients. Biol Blood Marrow Transplant. 2015, 21(7), 1334-1336. https://doi.org/10.1016/j.bbmt.2015.04.006
53. Lai T. P., Verhulst S., Dagnall C. L., Hutchinson A., Spellman S. R., Howard A., Katki H. A., Levine J. E., Saber W., Aviv A., Gadalla S. M. Decoupling blood telomere length from age in recipients of allogeneic hematopoietic cell transplant in the BMT-CTN 1202. Front. Immunol. 2022, 13, 966301. https://doi.org/10.3389/ fimmu.2022.966301
54. Goldberg J. L., Laughlin M. J. UC blood hematopoietic stem cells and therapeutic angiogenesis. Cytotherapy. 2007; 9(1), 4-13. https://doi. org/10.1080/14653240601139846
55. Chen Z., Chen L., Zeng C., Wang W.E. Functionally Improved Mesenchymal Stem Cells to Better Treat Myocardial Infarction. Stem Cells Int. 2018, 2018, 7045245. https://doi.org/10.1155/2018/7045245
56. Copeland N., Harris D, and Gaballa MA. Human umbilical cord blood stem cells, myocardial infarction and stroke. Clin. Med. 2009, 9(4), 342-345. https://doi. org/10.7861/clinmedicine.9-4-342,
57. Katarzyna R. Adult stem cell therapy for cardiac repair in patients after acute myocardial infarction leading to ischemic heart failure: an overview of evidence from the recent clinical trials. Curr. Cardiol. Rev. 2017, 13(3), 223-231. https://doi.org/10.2 174/1573403X13666170502103833
58. Rangappa S., Makkar R., and Forrester J. Review article: current status of myocardial regeneration: new cell sources and new strategies. J. Cardiovasc. Pharmacol. Ther. 2010, 15(4), 338-343. https://doi. org/10.1177/1074248410376382
59. Cui Y. X., Kafienah Wael, Suleiman M. S., Ascione R. A new methodological sequence to expand and transdifferentiate human umbilical cord blood derived CD133 cells into a cardiomyocyte-like phenotype. Stem Cell Reviews and Reports. 2013, 9(3), 350-359. https://doi.org/10.1007/s12015-011-9316-9
60. Hare J. M., Traverse J. H., Henry T. D., Dib N., Strumpf R. K., Schulman S. P., Gerstenblith G., DeMaria A. N., Denktas A. E., Gammon R. S, Hermiller J. B. Jr. Reisman M. A., Schaer G. L., Sherman W. A randomized, double-blind, placebo-controlled, doseescalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction. J. Am. Coll. Cardiol. 2009, 54, 2277-2286. https://doi. org/10.1016/j.jacc.2009.06.055
61. Bartolucci J., Verdugo F. J., Gonzalez P.L., Larrea R. E., Abarzua E., Goset C., Rojo P., Palma I., Lamich R., Pedreros P. A., Valdivia G., Lopez V. M., Nazzal C., Alcayaga-Miranda F., Cuenca J., Brobeck M. J., Patel A N, Figueroa F. E., Khoury M. Safety and Efficacy of the Intravenous Infusion of Umbilical Cord Mesenchymal Stem Cells in Patients With Heart Failure: A Phase 1/2 Randomized Controlled Trial (RIMECARD Trial [Randomized Clinical Trial of Intravenous Infusion Umbilical Cord Mesenchymal Stem Cells on Cardiopathy]). Circ Res. 2017, 121(10), 1192-1204. https://doi. org/10.1161/CIRCRESAHA.117.310712
62. Fedevych O., Chasovskyi K., Vorobiova G., Zhovnir V., Makarenko M., Kurkevych A., Maksymenko A., Yemets I. Open cardiac surgery in the first hours of life using autologous umbilical cord blood. Eur J Cardiothorac Surg. 2011, 40(4), 985-989. https://doi.org/10.1016/j.ejcts.2011.01.011
63. Chasovskyi K., Fedevych O., Vorobiova G., Zhovnir V., Maksimenko A., Boychenko O., Lysak Y., Cohen G., Yemets I. Arterial switch operation in the first hours of life using autologous umbilical cord blood. Ann Thorac Surg. 2012, 93(5), 1571-1576. https://doi. org/10.1016/j.athoracsur.2012.01.104
64. Badria A. F., Koutsoukos P. G., Mavrilas D. Decellularized tissue-engineered heart valves calcification: what do animal and clinical studies tell us? J. Mater. Sci. Mater. Med. 2020, 31(12), 132. https://doi.org/10.1007/ s10856-020-06462-x
65. Lutter G., Puehler T., Cyganek L., Seiler J., Rogler A., Herberth T., Knueppel P., Gorb S. N., Sathananthan J., Sellers S., Muller O.J., Frank D., Haben I. Biodegradable Poly- є-Caprolactone Scaffolds with ECFCs and iMSCs for Tissue-Engineered Heart Valves. Int. J. Mol. Sci. 2022, 23(1), 527. https://doi. org/10.3390/ijms23010527
66. Filova E., Straka F., Mirejovsky T., Masin J., Bacakova L. Tissue-engineered heart valves. Physiol. Res. 2009, 58 (2), S141-S158. https:// doi.org/10.33549/physiolres.931919
67. Pati F., Jang J., Ha D. H., Won Kim S., Rhie J. W., Shim J. H., Kim D. H., Cho D. W. Printing three-dimensional tissue analogues with decellularized extracellular matrix bioink. Nat Commun. 2014, 5, 3935. https://doi. org/10.1038/ncomms4935. PMID: 24887553
68. Fang N. T., Xie S. Z., Wang S. M., Gao H. Y., Wu C. G., Pan L. F. Construction of tissue- engineered heart valves by using decellularized scaffolds and endothelial progenitor cells. Chin. Med. J. (Engl.). 2007, 120(8), 696-702.
69. Schmidt D., Mol A., Breymann C., Achermann J., Odermatt B., Gossi M., Neuenschwander S., Pretre R., Genoni M., Zund G., Hoerstrup S. P. Living autologous heart valves engineered from human prenatally harvested progenitors. Circulation. 2006, 114(1), 1125-1131. https://doi.org/10.1161/
CIRCULATIONAHA.105.001040
70. Haverich A. Cardiac tissue engineering. Eur. J. Cardiothorac. Surg. 2008, 34(2), 227-228. https://doi.org/10.1016/j.ejcts.2008.05.013
71. Latifi N., Lecce M., Simmons C. A. Porcine Umbilical Cord Perivascular Cells for Preclinical Testing of Tissue-Engineered Heart Valves. Tissue Eng. Part. C Methods. 2021, 27(1), 35-46. https://doi. org/10.1089/ten.TEC.2020.0314
72. Ground M., Waqanivavalagi S., Walker R., Milsom P., Cornish J. Models of immunogenicity in preclinical assessment of tissue engineered heart valves. Acta Biomater. 2021, 133, 102-113. https://doi. org/10.1016/j.actbio.2021.05.049
73. Yoon C. H., Kim T. W., Koh S. J., Choi Y. E., Hur J., Kwon Y. W., Cho H. J., and Kim H. S. Gata6 in pluripotent stem cells enhance the potential to differentiate into cardiomyocytes. BMB Rep. 2018, 51(2), 85-91. https://doi. org/10.5483/BMBRep.2018.51.2.176
74. Janic B., and Arbab A. S. Cord blood endothelial progenitor cells as therapeutic and imaging probes. Imaging Med. 2012, 4(4), 477-490. https://doi.org/10.2217/ iim.12.35
75. Lee J. H., Kim S. W., Ji S. T., Kim Y. J., Jang W. B., Oh J. W., Kim J., Yoo S. Y., Beak S. H., Kwon S.M. Engineered M13 Nanofiber Accelerates Ischemic Neovascularization by Enhancing Endothelial Progenitor Cells. Tissue Eng. Regen. Med. 2017, 14(6), 787-802. https:// doi.org/10.1007/s13770-017-0074-x
76. Sun K., Zhou Z., Ju X., Zhou Y., Lan J., Chen D., Chen H., Liu M., Pang L. Combined transplantation of mesenchymal stem cells and endothelial progenitor cells for tissue engineering: a systematic review and metaanalysis. Stem Cell Res Ther. 2016, 7(1), 151. https://doi.org/10.1186/s13287-016-0390-4
77. Alonzo M., AnilKumar S., Roman B., Tasnim N., Joddar B. 3D Bioprinting of cardiac tissue and cardiac stem cell therapy. Transl Res. 2019, 211, 64-83. https://doi. org/10.1016/j.trsl.2019.04.004
78. Lueders C., Jastram B., Hetzer R., Schwandt H. Rapid manufacturing techniques for the tissue engineering of human heart valves. Eur J Cardiothorac Surg. 2014, 46(4), 593601. https://doi.org/10.1093/ejcts/ezt510
79. Kupfer M. E., Lin W. H., Ravikumar V., Qiu K., Wang L., Gao L., Bhuiyan D. B., Lenz M., Ai J., Mahutga R. R., Townsend D., Zhang J., McAlpine M. C., Tolkacheva E. G., Ogle B. M. In Situ Expansion, Differentiation, and Electromechanical Coupling of Human Cardiac Muscle in a 3D Bioprinted, Chambered Organoid. Circ. Res. 2020, 127(2), 207-224. https://doi.org/10.1161/ CIRCRESAHA.119.316155
80. OngC. S., Fukunishi T., ZhangH., Huang C. Y., Nashed A., Blazeski A., DiSilvestre D., Vricel- la L., Conte J., Tung L., Tomaselli G. F., Hibino N. Bio mat erial-Free Three-Dimensional Bioprinting of Cardiac Tissue using Human Induced Pluripotent Stem Cell Derived Cardiomyocytes. Sci Rep. 2017, 7(1), 4566. https://doi.org/10.1038/s41598-017-05018-4
81. Harrell C.R., Fellabaum C., Jovicic N., Djonov V., Arsenijevic N., Vola- revic V. Molecular Mechanisms Responsible for Therapeutic Potential of Mesenchymal Stem Cell-Derived Secretome. Cells. 2019, 16;8(5), 467. https://doi.org/10.3390/ cells8050467. PMID: 31100966; PMCID: PMC6562906.
82. Nazari-Shafti T.Z., Neuber S., Garcia Duran A.,
Xu Z., Beltsios E., Seifert M., Falk V., Stamm C. Human mesenchymal stromal cells and derived extracellular vesicles: Translational strategies to increase their proangiogenic potential for the treatment of cardiovascular disease. Stem Cells Transl Med. 2020, 9(12), 1558-1569. https://doi.org/10.1002/sctm.19-0432
83. Sun S. J., Wei R., Li F., Liao S. Y., Tse H. F. Mesenchymal stromal cell-derived exosomes in cardiac regeneration and repair. Stem Cell Reports. 2021, 16(7), 1662-1673. https:// doi.org/10.1016/j.stemcr.2021.05.003
Размещено на Allbest.ru
...Подобные документы
Causes of ischemic stroke. Assessment of individual risk for cardiovascular disease in humans. The development in patients of hypertension and coronary heart disease. Treatment in a modern hospital disorders biomarkers of coagulation and fibrinolysis.
статья [14,8 K], добавлен 18.04.2015The physiological, hygienic and epidemiological value of water. Diseases associated with water factor. Measures to prevent transmission of infectious diseases through the water. Influence of biological factors on survival of microorganisms in water.
презентация [762,9 K], добавлен 17.05.2016Concept and characteristics of focal pneumonia, her clinical picture and background. The approaches to the diagnosis and treatment of this disease, used drugs and techniques. Recent advances in the study of focal pneumonia. The forecast for recovery.
презентация [1,5 M], добавлен 10.11.2015Etiology and pathogenesis, types, treatment of pulpits. Inflammation of dental pulp. An infection (microorganisms) which penetrats in the cavity of pulp chamber. Test of healthy pulp. Tapping of tooth directly. Root canal treatment. Tooth extraction.
презентация [851,9 K], добавлен 31.05.2016The major pathogens and symptoms of cholera - an acute intestinal anthroponotic infection caused by bacteria of the species Vibrio cholerae. Methods of diagnosis and clinical features of disease. Traditional methods of treatment and prevention of disease.
презентация [1,0 M], добавлен 22.09.2014Features of the structure and anatomy of the heart, it's main functions and tasks in the body. Changes taking place in the human heart in the course of his life from birth to aging. Age-related disorders in the blood supply system and the heart.
презентация [725,8 K], добавлен 16.10.2016Introduction to the functionality of the most important internal organs. The main causes of supraventricular and ventricular tachycardia. Features of the structure and basic functions of the human heart. The study of the three phases of the heart.
презентация [3,8 M], добавлен 12.05.2013Agranulocytosis - pathologic condition, which is characterized by a greatly decreased number of circulating neutrophils. Epidemiology and pathophysiology of this disease. Hereditary disease due to genetic mutations. Signs and symptoms, treatment.
презентация [1,8 M], добавлен 25.02.2014Pneumonia is an inflammatory condition of the lung—affecting primarily the microscopic air sacs known as alveoli. The bacterium Streptococcus pneumoniae is a common cause of pneumonia. Symptoms, diagnostics, treatment and prevention of this disease.
презентация [279,8 K], добавлен 12.11.2013Principles and types of screening. Medical equipment used in screening. identify The possible presence of an as-yet-undiagnosed disease in individuals without signs or symptoms. Facilities for diagnosis and treatment. Common screening programmes.
презентация [921,2 K], добавлен 21.02.2016The complement system - part of the immune system as a set of complex proteins. History of the concept. Its biological functions, regulation, role in diseases. Stages of activation: the alternative and lectin pathway. Mannose-binding Lectin deficiency.
презентация [932,7 K], добавлен 17.03.2017Gastroesophageal reflux disease. Factors contributing to its the development. Esophageal symptoms of GERD. Aim of treatment. Change the life style. A basic medical treatment for GERD includes the use of prokinetic drugs with antisecretory agents.
презентация [390,7 K], добавлен 27.03.2016Infectious hepatitis - a widespread acute contagious disease. Botkin’s Disease is a viral disease that destroys the liver and bile ducts. Anatomy of the liver. The value of the liver to the body. Causes and signs of the disease. Treatment and prevention.
презентация [4,0 M], добавлен 24.04.2014Learning about peptic ulcers, a hole in the gut lining of the stomach, duodenum or esophagus. Symptoms of a peptic ulcer. Modified classification of gastroduodenal ulcers. Macroscopic and microscopic appearance. Differential diagnosis and treatment.
презентация [1,2 M], добавлен 22.04.2014Body Water Compartments. The main general physico-chemical laws. Disorders of water and electrolyte balance. Methods bodies of water in the body, and clinical manifestations. Planning and implementation of treatment fluid and electrolyte disorders.
презентация [1,1 M], добавлен 11.09.2014Tachycardia is a heart rate that exceeds the normal range. Symptoms and treatment methods of tachycardia. An electrocardiogram (ECG) is used to classify the type of tachycardia. It's important to get a prompt, accurate diagnosis and appropriate care.
презентация [596,2 K], добавлен 20.11.2014Teratology is the science of the etiology, pathogenesis, clinical and morphological characteristics, prevention and treatment of congenital malformations. History and the stages of its formation and development. Etiology of congenital malformations.
презентация [873,8 K], добавлен 23.09.2014Respiratory system brief. Structure of the Lungs. Structure of the Lungs. Examples of ailments of the lung: asthma, emphysema, pneumonia, tuberculosis. The characteristics and causes of diseases that cause them.. Visual of healthy vs. non healthy lungs.
презентация [162,8 K], добавлен 27.11.2013Testosterone is the primary male sex hormone that is present in both men and women. How to get a test for testosterone correctly. Testosterone in men: the norm and deviation. What diseases involve reduction of testosterone. Too much testosterone.
презентация [498,5 K], добавлен 26.05.2013Epilepsy is a group of neurological diseases characterized by epileptic seizures. Epileptic seizures are episodes that can vary from brief and nearly undetectable to long periods of vigorous shaking. Differential diagnosis and prevention of epilepsy.
презентация [39,6 K], добавлен 28.12.2015
